Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Biochimie ; 99: 189-94, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24333987

RESUMO

The widely expressed mammalian glucose transporter, GLUT1, can be acutely activated in L929 fibroblast cells by a variety of conditions, including glucose deprivation, or treatment with various respiration inhibitors. Known thiol reactive compounds including phenylarsine oxide and nitroxyl are the fastest acting stimulators of glucose uptake, implicating cysteine biochemistry as critical to the acute activation of GLUT1. In this study, we report that in L929 cells glucose uptake increases 6-fold as the pH of the uptake solution is increased from 6 to 9 with the half-maximal activation at pH 7.5; consistent with the pKa of cysteine residues. This pH effect is essentially blocked by the pretreatment of the cells with either iodoacetamide or cinnamaldehyde, compounds that form covalent adducts with reduced cysteine residues. In addition, the activation by alkaline pH is not additive at pH 8 with known thiol reactive activators such as phenylarsine oxide or hydroxylamine. Kinetic analysis in L929 cells at pH 7 and 8 indicate that alkaline conditions both increases the Vmax and decreases the Km of transport. This is consistent with the observation that pH activation is additive to methylene blue, which activates uptake by increasing the Vmax, as well as to berberine, which activates uptake by decreasing the Km. This suggests that cysteine biochemistry is utilized in both methylene blue and berberine activation of glucose uptake. In contrast a pH increase from 7 to 8 in HCLE cells does not further activate glucose uptake. HCLE cells have a 25-fold higher basal glucose uptake rate than L929 cells and the lack of a pH effect suggests that the cysteine biochemistry has already occurred in HCLE cells. The data are consistent with pH having a complex mechanism of action, but one likely mediated by cysteine biochemistry.


Assuntos
Fibroblastos/metabolismo , Transportador de Glucose Tipo 1/metabolismo , Acroleína/análogos & derivados , Acroleína/farmacologia , Animais , Arsenicais/farmacologia , Berberina/farmacologia , Transporte Biológico , Linhagem Celular , Cistina/metabolismo , Desoxiglucose/metabolismo , Ativadores de Enzimas/farmacologia , Humanos , Concentração de Íons de Hidrogênio , Cinética , Azul de Metileno/farmacologia , Camundongos , Substâncias Redutoras/farmacologia
2.
Biochimie ; 95(4): 787-92, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23201556

RESUMO

Nitroxyl (HNO) has a unique, but varied, set of biological properties including beneficial effects on cardiac contractility and stimulation of glucose uptake by GLUT1. These biological effects are largely initiated by HNO's reaction with cysteine residues of key proteins. The intracellular production of HNO has not yet been demonstrated, but the small molecule, hydroxylamine (HA), has been suggested as possible intracellular source. We examined the effects of this molecule on glucose uptake in L929 fibroblast cells. HA activates glucose uptake from 2 to 5-fold within two minutes. Prior treatment with thiol-active compounds, such as iodoacetamide (IA), cinnamaldehyde (CA), or phenylarsine oxide (PAO) blocks HA-activation of glucose uptake. Incubation of HA with the peroxidase inhibitor, sodium azide, also blocks the stimulatory effects of HA. This suggests that HA is oxidized to HNO by L929 fibroblast cells, which then reacts with cysteine residues to exert its stimulatory effects. The data suggest that GLUT1 is acutely activated in L929 cells by modification of cysteine residues, possibly the formation of a disulfide bond within GLUT1 itself.


Assuntos
Fibroblastos/metabolismo , Glucose/metabolismo , Hidroxilamina/farmacologia , Acroleína/análogos & derivados , Acroleína/farmacologia , Animais , Arsenicais/farmacologia , Azidas/farmacologia , Transporte Biológico/efeitos dos fármacos , Linhagem Celular , Relação Dose-Resposta a Droga , Fibroblastos/efeitos dos fármacos , Transportador de Glucose Tipo 1/metabolismo , Hidroxilamina/antagonistas & inibidores , Iodoacetamida/farmacologia , Camundongos , Fatores de Tempo
3.
Biochimie ; 95(2): 258-63, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23009931

RESUMO

The corneal epithelial tissue is a layer of rapidly growing cells that are highly glycolytic and express GLUT1 as the major glucose transporter. It has been shown that GLUT1 in L929 fibroblast cells and other cell lines can be acutely activated by a variety agents. However, the acute regulation of glucose uptake in corneal cells has not been systematically investigated. Therefore, we examined glucose uptake in an immortalized human corneal-limbal epithelial (HCLE) cell line and compared it to glucose uptake in L929 fibroblast cells, a cell line where glucose uptake has been well characterized. We report that the expression of GLUT1 in HCLE cells is 6.6-fold higher than in L929 fibroblast cells, but the HCLE cells have a 25-fold higher basal rate of glucose uptake. Treatment with agents that interfere with mitochondrial metabolism, such as sodium azide and berberine, activate glucose uptake in L929 cells over 3-fold, but have no effect on glucose uptake HCLE cells. Also, agents known to react with thiols, such cinnamaldehyde, phenylarsine oxide and nitroxyl stimulate glucose uptake in L929 cells 3-4-fold, but actually inhibit glucose uptake in HCLE cells. These data suggest that in the fast growing HCLE cells, GLUT1 is expressed at a higher concentration and is already highly activated at basal conditions. These data support a model for the acute activation of GLUT1 that suggests that the activity of GLUT1 is enhanced by the formation of an internal disulfide bond within GLUT1 itself.


Assuntos
Células Epiteliais/efeitos dos fármacos , Fibroblastos/efeitos dos fármacos , Regulação da Expressão Gênica/efeitos dos fármacos , Transportador de Glucose Tipo 1/metabolismo , Glucose/metabolismo , Acroleína/análogos & derivados , Acroleína/farmacologia , Animais , Arsenicais/farmacologia , Berberina/farmacologia , Transporte Biológico/efeitos dos fármacos , Linhagem Celular , Dissulfetos/química , Células Epiteliais/citologia , Células Epiteliais/metabolismo , Fibroblastos/citologia , Fibroblastos/metabolismo , Transportador de Glucose Tipo 1/agonistas , Transportador de Glucose Tipo 1/antagonistas & inibidores , Humanos , Cinética , Limbo da Córnea/citologia , Limbo da Córnea/efeitos dos fármacos , Limbo da Córnea/metabolismo , Camundongos , Óxidos de Nitrogênio/farmacologia , Especificidade de Órgãos , Azida Sódica/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA